DNA News & Events

Reports Q1 revenue $19.47M, consensus $42.96M. "We believe autonomous labs will replace the lab bench more quickly than people think," said Jason Kelly, CEO. "Nebula is already the world's largest autonomous lab with the ability to run real customer science around the clock and we're targeting to double its size this year. We see a large market that remains overwhelmingly manual today, and every experiment our Solutions, Datapoints, and Cloud Lab businesses run on Nebula generates revenue today while making the platform better for tomorrow. Ginkgo is singularly focused on leading the transition from the lab bench to autonomous research infrastructure that runs 24/7 and integrates directly with the AI models transforming drug discovery and industrial biotechnology."

Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M)

Reports Q4 GAAP net loss of ($81M) compared to ($108M) in the comparable prior year period . "This year, we are going to focus on investing to win in the category of autonomous labs," said Jason Kelly, co-founder and CEO of Ginkgo Bioworks. "There is an emerging wave of interest in robotics and AI, and our work with the Department of Energy and OpenAI this year shows that Ginkgo is in the best position to bring robotics to an extraordinarily high value area: laboratory research."